Replies to post #253309 on Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

It may be time to shine! I’d pay 18000 for a good article on the WallStreet J for IPIX. Word needs to get out that we are sniffing a 2 billion market as a leader.

[LilyGDog]

BooDog - Thank you , Awesome article! This article really makes IPIX stand out from the Galera trial.

In the Galera trial, treatment with GC4419 in the higher cisplatin group reduced the relative incidence of SOM by 41% compared to placebo in the Intent-to-Treat (ITT) population. In the ITT – IMRT (intensity-modulated radiation therapy) population, the relative incidence of SOM decreased by 39% versus placebo.

In the IPIX trial, treatment with Brilacidin in the modified Intent-to-Treat (mITT) population reduced the relative incidence of SOM by 65.0% compared to placebo. In the Per Protocol population, the relative incidence of SOM decreased by 80.3% compared to placebo.

To elaborate, understand that "per protocol" means that the principal investigator was certain that the patient followed Brilacidin therapy as directed. It bears repeating that, while the sample size was small for this group, treatment with Brilacidin oral rinse lowered the rate of SOM by over 80%.

Remember when shares of Vivus, Inc. (NASDAQ: VVUS) and Arena Pharmaceuticals (NASDAQ: ARNA) were rifling upwards (about 400% for VVUS and 1,000% for ARNA) in 2011 and 2012 ahead of and following the FDA decisions to approve their competing obesity drugs Qsymia (VVUS) and Belviq (ARNA)? Given the market opportunity for SOM and these two at the head of the class, market participants will surely start paying attention to Galera and IPIX in 2019 for a similar type chase. For publicly-listed IPIX, whatever weight has been holding the stock down may finally be lifted so that the company can achieve a fair valuation alongside its money-raising peer so that the stock can rise from its current depressed level.

New Baystreet article. Break the 100k volume, then break the .17 - .21 resistance.... game on.

http://www.baystreet.ca/stockstowatch/5021/A-Look-at-New-Oral-Mucositis-Drugs-Galera-Therapeutics-Capital-Raise-Points-to-Innovation-Pharmaceuticals-Being-Grossly-Undervalued

Third party compensation for advertising.

Go Leo & IPIX!

[Rdunn88]

Leo compensates Baystreet 1800 bucks for advertisements.. Again, worthless publicity.

Baystreet.ca has been compensated one thousand eight hundred dollars by a third party for Innovation Pharmaceuticals advertising.

http://www.baystreet.ca/stockstowatch/5021/A-Look-at-New-Oral-Mucositis-Drugs-Galera-Therapeutics-Capital-Raise-Points-to-Innovation-Pharmaceuticals-Being-Grossly-Undervalued

[TheDane]

It’s a good article, filled with FACTS. It makes no difference whether it was paid for by a third party as long as the information is accurate and true. ALL WRITERS GET PAID, Even dim bulb Mako. (Speaking of whom, why do they all look like that banjo player in Deliverance?!?! :-D)

[farrell90]

"Third party compensation for advertising"

JMO but we seem to need a little push to start our run up.

I am grateful for the help and pleasantly surprised someone would pay for the report.

God bless us, everyone

Farrell